Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders
- 1 April 1996
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 65 (4) , 796-799
- https://doi.org/10.1016/s0015-0282(16)58216-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The poor-responder patient in an in vitro fertilization-embryo transfer programJournal of Assisted Reproduction and Genetics, 1993
- The gonadotropin-releasing hormone agonist stimulation test—a sensitive predictor of performance in the flare-up in vitro fertilization cycleFertility and Sterility, 1991
- Comparison of ‘poor’ responders with ‘good’ responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilizationHuman Reproduction, 1991
- The Lupron screening test: tailoring the use of leuprolide acetate in ovarian stimulation for in vitro fertilizationFertility and Sterility, 1991
- Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilizationFertility and Sterility, 1990
- Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilizationFertility and Sterility, 1990
- Effect of maternal age and number of in vitro fertilization procedures on pregnancy outcomeFertility and Sterility, 1989
- Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcomeFertility and Sterility, 1989
- Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrievalFertility and Sterility, 1989
- Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilizationFertility and Sterility, 1989